Cite
APA Citation
Das, A., & Dean, A. (n.d.). p-304Modified FOLFIRINOX as a second-line treatment in pancreatic adenocarcinoma following gemcitabine plus nab-paclitaxel failure in patients with performance status two or less. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100094626389.0x00002b